Loading...
XLON
VCT
Market cap779mUSD
Jul 09, Last price  
667.00GBP
1D
1.37%
1Q
7.58%
Jan 2017
-65.46%
Name

Victrex PLC

Chart & Performance

D1W1MN
XLON:VCT chart
P/E
20.89
P/S
1.96
EPS
0.32
Div Yield, %
8.93%
Shrs. gr., 5y
0.25%
Rev. gr., 5y
2.19%
Revenues
296m
+0.07%
122,516,000131,025,000141,117,000103,822,000189,500,000215,800,000219,800,000221,900,000252,600,000263,500,000252,300,000290,200,000326,000,000294,000,000266,000,000306,300,000341,000,000307,000,000296,200,000296,400,000
Net income
28m
+61.63%
31,836,00036,420,00039,072,00017,839,00054,000,00071,200,00071,900,00072,900,00080,200,00083,500,00082,500,00099,500,000110,600,00092,400,00054,200,00073,200,00076,200,00061,700,00017,200,00027,800,000
CFO
71m
-15.36%
42,526,00038,204,00045,979,00015,598,00077,100,00065,400,00066,000,00080,000,00097,800,00087,600,00083,400,000117,600,000129,000,00080,100,00069,400,000127,100,00080,000,00040,800,00084,000,00071,100,000
Dividend
Jan 29, 202646.14 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating globally through its subsidiaries, Victrex plc is a specialized producer and distributor of polymer materials. The company organizes its business into two core divisions: Industrial and Medical. It concentrates on creating PEEK and PAEK polymer-based solutions, delivering both partially processed and fully manufactured components. Furthermore, Victrex offers tailored solutions for medical device producers, markets thermoplastic polymer components, and conducts trading operations. Its diverse clientele spans the automotive, aerospace, energy, industrial, manufacturing, engineering, electronics, and healthcare industries. Established in 1993, Victrex plc maintains its corporate headquarters in Thornton-Cleveleys, United Kingdom.
IPO date
Dec 13, 1995
Employees
1,093
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑092024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑09
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT